vs
C3.ai, Inc.(AI)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是C3.ai, Inc.的1.0倍($75.5M vs $75.1M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -20.3%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-46.9M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -2.1%)
C3.ai是全球领先的企业级人工智能软件供应商,主要开发销售可扩展的AI应用、平台工具及垂直行业定制解决方案,服务覆盖制造、能源、金融、医疗、公共部门等领域,助力客户优化运营、降本增效、管控风险,实现数据驱动的业务决策。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
AI vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$75.1M
营收增速更快
PBYI
高出48.1%
-20.3%
自由现金流更多
PBYI
多$61.3M
$-46.9M
两年增速更快
PBYI
近两年复合增速
-2.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $75.1M | $75.5M |
| 净利润 | $-104.7M | — |
| 毛利率 | 40.4% | 69.3% |
| 营业利润率 | -149.2% | 22.7% |
| 净利率 | -139.3% | — |
| 营收同比 | -20.3% | 27.7% |
| 净利润同比 | -58.7% | — |
| 每股收益(稀释后) | $-0.75 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AI
PBYI
| Q4 25 | $75.1M | $75.5M | ||
| Q3 25 | $70.3M | $54.5M | ||
| Q2 25 | $108.7M | $52.4M | ||
| Q1 25 | $98.8M | $46.0M | ||
| Q4 24 | $94.3M | $59.1M | ||
| Q3 24 | $87.2M | $80.5M | ||
| Q2 24 | $86.6M | $47.1M | ||
| Q1 24 | $78.4M | $43.8M |
净利润
AI
PBYI
| Q4 25 | $-104.7M | — | ||
| Q3 25 | $-116.8M | $8.8M | ||
| Q2 25 | $-79.7M | $5.9M | ||
| Q1 25 | $-80.2M | $3.0M | ||
| Q4 24 | $-66.0M | — | ||
| Q3 24 | $-62.8M | $20.3M | ||
| Q2 24 | $-72.9M | $-4.5M | ||
| Q1 24 | $-72.6M | $-4.8M |
毛利率
AI
PBYI
| Q4 25 | 40.4% | 69.3% | ||
| Q3 25 | 37.6% | 77.7% | ||
| Q2 25 | 62.1% | 76.5% | ||
| Q1 25 | 59.1% | 77.1% | ||
| Q4 24 | 61.3% | 76.4% | ||
| Q3 24 | 59.8% | 63.9% | ||
| Q2 24 | 59.6% | 77.4% | ||
| Q1 24 | 57.8% | 75.5% |
营业利润率
AI
PBYI
| Q4 25 | -149.2% | 22.7% | ||
| Q3 25 | -177.7% | 17.6% | ||
| Q2 25 | -81.8% | 12.7% | ||
| Q1 25 | -88.7% | 8.7% | ||
| Q4 24 | -79.8% | 22.6% | ||
| Q3 24 | -83.2% | 27.4% | ||
| Q2 24 | -95.1% | -4.6% | ||
| Q1 24 | -105.3% | -5.3% |
净利率
AI
PBYI
| Q4 25 | -139.3% | — | ||
| Q3 25 | -166.2% | 16.2% | ||
| Q2 25 | -73.3% | 11.2% | ||
| Q1 25 | -81.2% | 6.5% | ||
| Q4 24 | -69.9% | — | ||
| Q3 24 | -72.0% | 25.2% | ||
| Q2 24 | -84.2% | -9.6% | ||
| Q1 24 | -92.6% | -11.0% |
每股收益(稀释后)
AI
PBYI
| Q4 25 | $-0.75 | $0.26 | ||
| Q3 25 | $-0.86 | $0.17 | ||
| Q2 25 | $-0.60 | $0.12 | ||
| Q1 25 | $-0.62 | $0.06 | ||
| Q4 24 | $-0.52 | $0.40 | ||
| Q3 24 | $-0.50 | $0.41 | ||
| Q2 24 | $-0.59 | $-0.09 | ||
| Q1 24 | $-0.60 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $675.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $771.9M | $130.3M |
| 总资产 | $961.3M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
AI
PBYI
| Q4 25 | $675.0M | $97.5M | ||
| Q3 25 | $711.9M | $94.4M | ||
| Q2 25 | $742.7M | $96.0M | ||
| Q1 25 | $724.3M | $93.2M | ||
| Q4 24 | $730.4M | $101.0M | ||
| Q3 24 | $762.5M | $96.7M | ||
| Q2 24 | $750.4M | $96.8M | ||
| Q1 24 | $723.3M | $107.2M |
总债务
AI
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
AI
PBYI
| Q4 25 | $771.9M | $130.3M | ||
| Q3 25 | $798.8M | $115.3M | ||
| Q2 25 | $838.3M | $104.7M | ||
| Q1 25 | $860.2M | $97.1M | ||
| Q4 24 | $859.0M | $92.1M | ||
| Q3 24 | $874.9M | $71.1M | ||
| Q2 24 | $873.4M | $48.5M | ||
| Q1 24 | $898.0M | $51.0M |
总资产
AI
PBYI
| Q4 25 | $961.3M | $216.3M | ||
| Q3 25 | $968.7M | $202.9M | ||
| Q2 25 | $1.0B | $194.9M | ||
| Q1 25 | $1.1B | $196.2M | ||
| Q4 24 | $1.0B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.0B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比
AI
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-46.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-46.9M | $14.4M |
| 自由现金流率自由现金流/营收 | -62.4% | 19.1% |
| 资本支出强度资本支出/营收 | 0.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.2M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
AI
PBYI
| Q4 25 | $-46.5M | $14.4M | ||
| Q3 25 | $-33.5M | $9.7M | ||
| Q2 25 | $11.3M | $14.1M | ||
| Q1 25 | $-22.0M | $3.6M | ||
| Q4 24 | $-38.7M | $15.6M | ||
| Q3 24 | $8.0M | $11.0M | ||
| Q2 24 | $21.3M | $1.0M | ||
| Q1 24 | $-39.1M | $11.2M |
自由现金流
AI
PBYI
| Q4 25 | $-46.9M | $14.4M | ||
| Q3 25 | $-34.3M | $9.7M | ||
| Q2 25 | $10.3M | $14.1M | ||
| Q1 25 | $-22.4M | $3.6M | ||
| Q4 24 | $-39.5M | $15.6M | ||
| Q3 24 | $7.1M | $11.0M | ||
| Q2 24 | $18.8M | $1.0M | ||
| Q1 24 | $-45.1M | — |
自由现金流率
AI
PBYI
| Q4 25 | -62.4% | 19.1% | ||
| Q3 25 | -48.8% | 17.7% | ||
| Q2 25 | 9.5% | 26.8% | ||
| Q1 25 | -22.7% | 7.7% | ||
| Q4 24 | -41.9% | 26.4% | ||
| Q3 24 | 8.2% | 13.7% | ||
| Q2 24 | 21.7% | 2.1% | ||
| Q1 24 | -57.6% | — |
资本支出强度
AI
PBYI
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 2.9% | 0.0% | ||
| Q1 24 | 7.8% | 0.0% |
现金转化率
AI
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AI
| License And Service | $70.2M | 93% |
| Professional Services | $4.9M | 7% |
PBYI
暂无分部数据